Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Changes in thalamic dopamine innervation in a progressive Parkinson's disease model in monkeys.

Monje MHG, Blesa J, García-Cabezas MÁ, Obeso JA, Cavada C.

Mov Disord. 2019 Dec 4. doi: 10.1002/mds.27921. [Epub ahead of print]

PMID:
31800134
2.

Liberation and Micellarization of Carotenoids from Different Smoothies after Thermal and Ultrasound Treatments.

Buniowska M, Arrigoni E, Znamirowska A, Blesa J, Frígola A, Esteve MJ.

Foods. 2019 Oct 14;8(10). pii: E492. doi: 10.3390/foods8100492.

3.

Serotonergic innervation of the striatum in a nonhuman primate model of Parkinson's disease.

Jiménez-Sánchez L, Blesa J, Del Rey NL, Monje MHG, Obeso JA, Cavada C.

Neuropharmacology. 2019 Oct 4:107806. doi: 10.1016/j.neuropharm.2019.107806. [Epub ahead of print]

PMID:
31589886
4.

Systemic Exosomal Delivery of shRNA Minicircles Prevents Parkinsonian Pathology.

Izco M, Blesa J, Schleef M, Schmeer M, Porcari R, Al-Shawi R, Ellmerich S, de Toro M, Gardiner C, Seow Y, Reinares-Sebastian A, Forcen R, Simons JP, Bellotti V, Cooper JM, Alvarez-Erviti L.

Mol Ther. 2019 Dec 4;27(12):2111-2122. doi: 10.1016/j.ymthe.2019.08.010. Epub 2019 Aug 27.

PMID:
31501034
5.

Focused ultrasound in Parkinson's disease: A twofold path toward disease modification.

Foffani G, Trigo-Damas I, Pineda-Pardo JA, Blesa J, Rodríguez-Rojas R, Martínez-Fernández R, Obeso JA.

Mov Disord. 2019 Sep;34(9):1262-1273. doi: 10.1002/mds.27805. Epub 2019 Aug 14. Review.

PMID:
31412430
6.

Blood-brain barrier opening with focused ultrasound in experimental models of Parkinson's disease.

Karakatsani ME, Blesa J, Konofagou EE.

Mov Disord. 2019 Sep;34(9):1252-1261. doi: 10.1002/mds.27804. Epub 2019 Jul 30. Review.

PMID:
31361356
7.

Parkinson disease, substantia nigra vulnerability, and calbindin expression: Enlightening the darkness?

Blesa J, Vila M.

Mov Disord. 2019 Feb;34(2):161-163. doi: 10.1002/mds.27618. Epub 2019 Jan 24. No abstract available.

PMID:
30675930
8.

Advances in Parkinson's Disease: 200 Years Later.

Del Rey NL, Quiroga-Varela A, Garbayo E, Carballo-Carbajal I, Fernández-Santiago R, Monje MHG, Trigo-Damas I, Blanco-Prieto MJ, Blesa J.

Front Neuroanat. 2018 Dec 14;12:113. doi: 10.3389/fnana.2018.00113. eCollection 2018. Review.

9.

Expression of the human TIMM23 and TIMM23B genes is regulated by the GABP transcription factor.

Prieto-Ruiz JA, Alis R, García-Benlloch S, Sáez-Atiénzar S, Ventura I, Hernández-Andreu JM, Hernández-Yago J, Blesa JR.

Biochim Biophys Acta Gene Regul Mech. 2018 Feb;1861(2):80-94. doi: 10.1016/j.bbagrm.2018.01.006. Epub 2018 Feb 3.

PMID:
29413900
10.

Novel models for Parkinson's disease and their impact on future drug discovery.

Trigo-Damas I, Del Rey NL, Blesa J.

Expert Opin Drug Discov. 2018 Mar;13(3):229-239. doi: 10.1080/17460441.2018.1428556. Epub 2018 Jan 24. Review.

PMID:
29363335
11.

Compensatory mechanisms in Parkinson's disease: Circuits adaptations and role in disease modification.

Blesa J, Trigo-Damas I, Dileone M, Del Rey NL, Hernandez LF, Obeso JA.

Exp Neurol. 2017 Dec;298(Pt B):148-161. doi: 10.1016/j.expneurol.2017.10.002. Epub 2017 Oct 4. Review.

PMID:
28987461
12.

Untargeted metabolomics of fresh and heat treatment Tiger nut (Cyperus esculentus L.) milks reveals further insight into food quality and nutrition.

Rubert J, Monforte A, Hurkova K, Pérez-Martínez G, Blesa J, Navarro JL, Stranka M, Soriano JM, Hajslova J.

J Chromatogr A. 2017 Sep 8;1514:80-87. doi: 10.1016/j.chroma.2017.07.071. Epub 2017 Jul 23.

PMID:
28768579
13.

Early Paradoxical Increase of Dopamine: A Neurochemical Study of Olfactory Bulb in Asymptomatic and Symptomatic MPTP Treated Monkeys.

Pifl C, Reither H, Del Rey NL, Cavada C, Obeso JA, Blesa J.

Front Neuroanat. 2017 May 29;11:46. doi: 10.3389/fnana.2017.00046. eCollection 2017.

14.

The use of nonhuman primate models to understand processes in Parkinson's disease.

Blesa J, Trigo-Damas I, Del Rey NL, Obeso JA.

J Neural Transm (Vienna). 2018 Mar;125(3):325-335. doi: 10.1007/s00702-017-1715-x. Epub 2017 Mar 29. Review.

PMID:
28357564
15.

Parkinson's disease: Oh my gut!

Del Rey NL, Blesa J.

Mov Disord. 2017 Mar;32(3):396. doi: 10.1002/mds.26933. Epub 2017 Feb 2. No abstract available.

PMID:
28151555
16.

Ethical aspects of nuclear and mitochondrial DNA transfer.

Blesa JR, Tudela J, Aznar J.

Linacre Q. 2016 May;83(2):179-191.

17.

Extracellular vesicles in food: Experimental evidence of their secretion in grape fruits.

Pérez-Bermúdez P, Blesa J, Soriano JM, Marcilla A.

Eur J Pharm Sci. 2017 Feb 15;98:40-50. doi: 10.1016/j.ejps.2016.09.022. Epub 2016 Sep 21.

PMID:
27664331
18.

Parkinson's disease and thalamus: facts and fancy.

Blesa J, Trigo-Damas I, Obeso JA.

Lancet Neurol. 2016 Jun;15(7):e2. doi: 10.1016/S1474-4422(16)30048-5. Epub 2016 May 9. No abstract available.

PMID:
27302241
19.

Selective connectivity of dopamine neurons projecting to the posterior striatum.

del Rey NL, Blesa J.

Mov Disord. 2016 Mar;31(3):298. doi: 10.1002/mds.26496. Epub 2016 Feb 10. No abstract available.

PMID:
26861629
20.

Vive la difference! Dissecting the diversity of midbrain dopamine neurons.

Blesa J.

Mov Disord. 2016 Jan;31(1):41. doi: 10.1002/mds.26487. Epub 2015 Dec 21. No abstract available.

PMID:
26686701
21.

Editorial: Parkinson's disease: cell vulnerability and disease progression.

Blesa J, Lanciego JL, Obeso JA.

Front Neuroanat. 2015 Sep 15;9:125. doi: 10.3389/fnana.2015.00125. eCollection 2015. No abstract available.

22.

Bcl-xL-mediated antioxidant function abrogates the disruption of mitochondrial dynamics induced by LRRK2 inhibition.

Saez-Atienzar S, Bonet-Ponce L, da Casa C, Perez-Dolz L, Blesa JR, Nava E, Galindo MF, Jordan J.

Biochim Biophys Acta. 2016 Jan;1862(1):20-31. doi: 10.1016/j.bbadis.2015.09.021. Epub 2015 Oct 3.

23.

Oxidative stress and Parkinson's disease.

Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR.

Front Neuroanat. 2015 Jul 8;9:91. doi: 10.3389/fnana.2015.00091. eCollection 2015. Review.

24.

Identification of neurodegenerative factors using translatome-regulatory network analysis.

Brichta L, Shin W, Jackson-Lewis V, Blesa J, Yap EL, Walker Z, Zhang J, Roussarie JP, Alvarez MJ, Califano A, Przedborski S, Greengard P.

Nat Neurosci. 2015 Sep;18(9):1325-33. doi: 10.1038/nn.4070. Epub 2015 Jul 27.

25.

Effect of training status on the changes in platelet parameters induced by short-duration exhaustive exercise.

Alis R, Sanchis-Gomar F, Risso-Ballester J, Blesa JR, Romagnoli M.

Platelets. 2016;27(2):117-22. doi: 10.3109/09537104.2015.1047334. Epub 2015 May 29.

PMID:
26023745
26.

The role of mitochondrial derived peptides (MDPs) in metabolism.

Alis R, Lucia A, Blesa JR, Sanchis-Gomar F.

J Cell Physiol. 2015 Dec;230(12):2903-4. doi: 10.1002/jcp.25023. No abstract available.

PMID:
25893266
27.

α-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2.

Kett LR, Stiller B, Bernath MM, Tasset I, Blesa J, Jackson-Lewis V, Chan RB, Zhou B, Di Paolo G, Przedborski S, Cuervo AM, Dauer WT.

J Neurosci. 2015 Apr 8;35(14):5724-42. doi: 10.1523/JNEUROSCI.0632-14.2015.

28.

Inhibition of xanthine oxidase to prevent statin-induced myalgia and rhabdomiolysis.

Alis R, Sanchis-Gomar F, Risso-Ballester J, Perez-Quilis C, Cortell-Ballester J, Romagnoli M, Blesa JR, Emanuele E.

Atherosclerosis. 2015 Mar;239(1):38-42. doi: 10.1016/j.atherosclerosis.2014.12.055. Epub 2014 Dec 31.

PMID:
25568951
29.

Parkinson's disease: animal models and dopaminergic cell vulnerability.

Blesa J, Przedborski S.

Front Neuroanat. 2014 Dec 15;8:155. doi: 10.3389/fnana.2014.00155. eCollection 2014. Review.

30.

Hemoconcentration induced by exercise: Revisiting the Dill and Costill equation.

Alis R, Sanchis-Gomar F, Primo-Carrau C, Lozano-Calve S, Dipalo M, Aloe R, Blesa JR, Romagnoli M, Lippi G.

Scand J Med Sci Sports. 2015 Dec;25(6):e630-7. doi: 10.1111/sms.12393. Epub 2014 Dec 30.

PMID:
25557039
31.

Exercise effects on erythrocyte deformability in exercise-induced arterial hypoxemia.

Alis R, Sanchis-Gomar F, Ferioli D, La Torre A, Blesa JR, Romagnoli M.

Int J Sports Med. 2015 Apr;36(4):286-91. doi: 10.1055/s-0034-1394395. Epub 2014 Nov 27.

32.

Effect of exhaustive running exercise on red blood cell distribution width.

Alis R, Romagnoli M, Primo-Carrau C, Pareja-Galeano H, Blesa JR, Sanchis-Gomar F.

Clin Chem Lab Med. 2015 Feb;53(2):e29-31. doi: 10.1515/cclm-2014-0749. No abstract available.

PMID:
25153414
33.

VMAT2 and Parkinson's disease: old dog, new tricks.

Blesa J.

Mov Disord. 2014 Sep;29(10):1241. doi: 10.1002/mds.25986. Epub 2014 Aug 13. No abstract available.

PMID:
25124053
34.

The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling.

Saez-Atienzar S, Bonet-Ponce L, Blesa JR, Romero FJ, Murphy MP, Jordan J, Galindo MF.

Cell Death Dis. 2014 Aug 14;5:e1368. doi: 10.1038/cddis.2014.320.

35.

Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum.

Pifl C, Rajput A, Reither H, Blesa J, Cavada C, Obeso JA, Rajput AH, Hornykiewicz O.

J Neurosci. 2014 Jun 11;34(24):8210-8. doi: 10.1523/JNEUROSCI.5456-13.2014. Erratum in: J Neurosci. 2015 Nov 25;35(47):15767.

36.

Effects of bread making and wheat germ addition on the natural deoxynivalenol content in bread.

Giménez I, Blesa J, Herrera M, Ariño A.

Toxins (Basel). 2014 Jan 21;6(1):394-401. doi: 10.3390/toxins6010394.

37.

Presence of mycotoxins in sorghum and intake estimation in Tunisia.

Oueslati S, Blesa J, Moltó JC, Ghorbel A, Mañes J.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2014;31(2):307-18. doi: 10.1080/19440049.2013.867367. Epub 2014 Jan 31.

PMID:
24294980
38.

Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.

Recasens A, Dehay B, Bové J, Carballo-Carbajal I, Dovero S, Pérez-Villalba A, Fernagut PO, Blesa J, Parent A, Perier C, Fariñas I, Obeso JA, Bezard E, Vila M.

Ann Neurol. 2014 Mar;75(3):351-62. doi: 10.1002/ana.24066. Epub 2014 Feb 18.

PMID:
24243558
39.

Parkinson's disease: "Braak" to the future.

Blesa J.

Mov Disord. 2013 Aug;28(9):1209. doi: 10.1002/mds.25498. Epub 2013 Aug 12. No abstract available.

PMID:
23939718
40.

Durable complete remission of a brainstem glioma treated with a combination of bevacizumab and cetuximab.

Blesa JM, Mollá SB, Esparcia MF, Ortells JM, Godoy MP, Das AM, Magan BM, Pulla MP, Sanchez JL, Canales JB, Candel VA.

Case Rep Oncol. 2012 Sep;5(3):676-81. doi: 10.1159/000341852. Epub 2012 Dec 20.

41.

Reduced noradrenaline, but not dopamine and serotonin in motor thalamus of the MPTP primate: relation to severity of parkinsonism.

Pifl C, Hornykiewicz O, Blesa J, Adánez R, Cavada C, Obeso JA.

J Neurochem. 2013 Jun;125(5):657-62. doi: 10.1111/jnc.12162. Epub 2013 Feb 13.

42.

Evaluation of enniatins A, A1, B, B1 and beauvericin in Portuguese cereal-based foods.

Blesa J, Marín R, Lino CM, Mañes J.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2012;29(11):1727-35. doi: 10.1080/19440049.2012.702929. Epub 2012 Jul 30.

PMID:
22845312
43.

Sonic hedgehog maintains cellular and neurochemical homeostasis in the adult nigrostriatal circuit.

Gonzalez-Reyes LE, Verbitsky M, Blesa J, Jackson-Lewis V, Paredes D, Tillack K, Phani S, Kramer ER, Przedborski S, Kottmann AH.

Neuron. 2012 Jul 26;75(2):306-19. doi: 10.1016/j.neuron.2012.05.018.

44.

The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study.

Blesa J, Pifl C, Sánchez-González MA, Juri C, García-Cabezas MA, Adánez R, Iglesias E, Collantes M, Peñuelas I, Sánchez-Hernández JJ, Rodríguez-Oroz MC, Avendaño C, Hornykiewicz O, Cavada C, Obeso JA.

Neurobiol Dis. 2012 Oct;48(1):79-91. doi: 10.1016/j.nbd.2012.05.018. Epub 2012 Jun 5.

PMID:
22677034
45.

Classic and new animal models of Parkinson's disease.

Blesa J, Phani S, Jackson-Lewis V, Przedborski S.

J Biomed Biotechnol. 2012;2012:845618. doi: 10.1155/2012/845618. Epub 2012 Mar 28. Review.

46.

Comparison of three solid-phase extraction processes in quantification of ciprofloxacin and enrofloxacin in pork meat.

Blesa J, Silva LJ, Lino CM, Font G, Pena A.

J Sep Sci. 2012 Apr;35(7):832-8. doi: 10.1002/jssc.201100971.

PMID:
22532351
47.

Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson's disease.

Blesa J, Juri C, García-Cabezas MÁ, Adánez R, Sánchez-González MÁ, Cavada C, Obeso JA.

Front Syst Neurosci. 2011 Nov 24;5:92. doi: 10.3389/fnsys.2011.00092. eCollection 2011.

48.

Animal models of Parkinson's disease.

Jackson-Lewis V, Blesa J, Przedborski S.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S183-5. doi: 10.1016/S1353-8020(11)70057-8. Review.

PMID:
22166429
49.

Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study.

Blesa J, Juri C, Collantes M, Peñuelas I, Prieto E, Iglesias E, Martí-Climent J, Arbizu J, Zubieta JL, Rodríguez-Oroz MC, García-García D, Richter JA, Cavada C, Obeso JA.

Neurobiol Dis. 2010 Jun;38(3):456-63. doi: 10.1016/j.nbd.2010.03.006. Epub 2010 Mar 19.

PMID:
20304066
50.

Further data on the presence of Fusarium emerging mycotoxins enniatins, fusaproliferin and beauvericin in cereals available on the Spanish markets.

Meca G, Zinedine A, Blesa J, Font G, Mañes J.

Food Chem Toxicol. 2010 May;48(5):1412-6. doi: 10.1016/j.fct.2010.03.010. Epub 2010 Mar 15.

PMID:
20230871

Supplemental Content

Support Center